Background Image
Previous Page  39 / 39
Information
Show Menu
Previous Page 39 / 39
Page Background

39

risedronate for Paget's disease. N Engl J Med.

2005;353:898.

49.

Ralston SH, Langston AL, Reid IR. Pathogenesis

and management of Paget's disease of bone.

Lancet. 2008;372:155.

50.

Woitge HW,

Oberwittler H,

Heichel S.

Short

and long-term effects of ibandronate treatment

on bone turnover in Paget disease of bone.

Clin Chem

2000;46:684-90.

51.

Reid IR, Miller P, Lyles K, Fraser W, Brown JP,

Saidi Y, et al. Comparison of a single infusion of

zoledronic acid with risedronate for Paget's

disease. N Engl J Med 2005;353:898-908.

52.

Reid IR.

Pharmacotherapy of Paget's disease of

bone

. Expert Opin Pharmacother

2012;13:637-46.

53.

Langston AL,

Campbell MK,

Fraser WD,

MacLennan GS, Selby PL, Ralston SH.

PRISMTrial Group. Randomized trial of

intensive bisphosphonate treatment versus

symptomatic management in Paget's disease of

bone

. J Bone Miner Res

2010;25:20-31.